主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
Rapid health technology assessment of lorlatinib in the first-line treatment of anaplastic lymphoma kinase mutation-positive non-small cell lung cancer
YAN Yuting# , SUN Jieyu# , LI Qian
World Clinical Drug . 2024, (3): 317 -323 .  DOI: 10.13683/j.wph.2024.03.013